Document is current
Any future updates will be listed below
-
Authors
Silverberg, Jonathan I. https://orcid.org/0000-0003-3686-7805
Simpson, Eric L. https://orcid.org/0000-0003-0853-0252
Pink, Andrew E. https://orcid.org/0000-0001-5151-5539
Weidinger, Stephan https://orcid.org/0000-0003-3944-252X
Chan, Gary
Biswas, Pinaki https://orcid.org/0009-0009-3494-4142
Clibborn, Claire https://orcid.org/0000-0002-2586-891X
Güler, Erman https://orcid.org/0009-0006-1240-5269
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 1 August 2024
Accepted: 27 November 2024
First Online: 4 February 2025
Declarations
:
: Jonathan I. Silverberg served as an investigator for Celgene, Eli Lilly and Company, F. Hoffmann-La Roche, Menlo Therapeutics, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; as a consultant for Pfizer Inc., AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Menlo Therapeutics, Novartis, Realm Therapeutics, Regeneron Pharmaceuticals, and Sanofi Genzyme; and as a speaker for Regeneron Pharmaceuticals and Sanofi Genzyme. Eric L. Simpson received grants from Pfizer Inc., Eli Lilly and Company, Kyowa Kirin, LEO Pharma, Merck, and Regeneron and personal fees from Pfizer Inc., Bausch Health (Valeant), Dermira, Eli Lilly and Company, Galderma, LEO Pharma, Menlo Therapeutics, Novartis, Regeneron, and Sanofi Genzyme. Andrew E. Pink has acted as an advisor or speaker for Pfizer Inc., AbbVie, Almirall, Elli Lilly and Company, Sanofi Genzyme, LEO Pharma, Janssen, Novartis, La Roche-Posay, and UCB. Stephan Weidinger has received institutional research grants from La Roche-Posay, LEO Pharma, and Sanofi Deutschland GmbH; has performed consultancies for Pfizer Inc., AbbVie, Eli Lilly and Company, Kymab, LEO Pharma, Novartis, Regeneron Pharmaceuticals, and Sanofi Genzyme; and has lectured at educational events sponsored by AbbVie, Galderma, LEO Pharma, Novartis, Regeneron Pharmaceuticals, and Sanofi Genzyme. Gary Chan, Pinaki Biswas, and Erman Güler are employees and shareholders of Pfizer Inc. Claire Clibborn is a former employee and current shareholder of Pfizer Ltd., and a current employee and shareholder of Ascendis Pharma.
: Study documents and procedures were approved by the appropriate institutional review boards/ethics committees at each study site. These trials were conducted in accordance with the ethical principles from the Declaration of Helsinki, International Ethical Guidelines for Biomedical Research Involving Human Subjects from the Council for International Organizations of Medical Sciences, and International Council for Harmonisation Good Clinical Practice Guidelines. Informed consent was obtained from all individual participants included in both trials.
